Metabolic Effects of an SGLT2 Inhibitor (Dapagliflozin) During a Period of Acute Insulin Withdrawal and Development of Ketoacidosis in People With Type 1 Diabetes

Overview of attention for article published in Diabetes Care, July 2020

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (97th percentile)
High Attention Score compared to outputs of the same age and source (91st percentile)

Mentioned by

news: 13 news outlets

twitter: 2 X users

Readers on

mendeley: 63 Mendeley

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 2,997 followers.

Metabolic Effects of an SGLT2 Inhibitor (Dapagliflozin) During a Period of Acute Insulin Withdrawal and Development of Ketoacidosis in People With Type 1 Diabetes | Diabetes Care https://t.co/UbkRkB3jnJ

Metabolic Effects of an SGLT2 Inhibitor (Dapagliflozin) During a Period of Acute Insulin Withdrawal and Development… https://t.co/pkSmefTucC

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.